IL6 and acute respiratory distress syndrome: Prior studies have assessed the effect of methylprednisolone on circulating cytokines in a secondary analysis of a clinical trial in ARDS and, consistent with our studies, demonstrated a decrease in circulating IL-6 [27], which may reflect a decrease in the proinflammatory response.